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Aims: Oestrogen has been speculated to play an important role in the pathogenesis of primary biliary 
cirrhosis (PBC), which mainly affects middle- and old-aged females, because biliary epithelial cells 
(BECs) are known to express oestrogen receptors (ERs). Oestrogen-related receptors (ERRs) are 
constitutively active without oestrogen and competitively inhibit the ER-dependent effects of 
oestrogen. We clarified the effects of oestrogen and the significance of ERRs along with their 
association with the pathogenesis of cholangiopathy in PBC. Methods: We investigated the 
expression of ERs and ERRs and the apoptosis-related cell kinetics in BECs using cultured human 
BECs and human liver specimens. Results: Although cultured human BECs and the interlobular bile 
ducts in the liver expressed ERβ, in cultured BECs, oestrogen treatment did not induce significant 
cell proliferation but increased the expression of a negative cell proliferation regulator (14-3-3σ 
protein). The cultured BECs constantly expressed ERRα and ERRγ, and oestrogen down-regulated 
the ERRγ expression. Furthermore, the ERRγ expression was determined in the intrahepatic bile 
ducts and was stronger in the middle- and old-aged females, particularly those with PBC, than in the 
younger females. The ERRγ ligand activated a transcription factor, SP1, and enhanced the 
expression of the pro-apoptotic Bcl-2 family molecules and Bcl-2 inhibitor-induced apoptosis in 
cultured BECs. Conclusion: Although oestrogen down-regulates the ERRγ expression, the increased 
ERRγ expression under oestrogen-deficient conditions increases the susceptibility to Bcl-2 
family-mediated apoptosis in cultured human BECs of females, particularly those with PBC. 
Understanding the oestrogen-mediated cell kinetics is important for elucidating the pathogenesis of 
cholangiopathy in PBC.  
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INTRODUCTION 
Primary biliary cirrhosis (PBC) mainly affects middle-aged females, where histologically, the 
interlobular bile ducts are damaged and reveals characteristics such as chronic non-suppurative 
destructive cholangitis (CNSDC), followed by progressive bile duct loss.1,2 There is considerable 
evidence that the damage of bile ducts is mediated by auto-reactive T cells, monocytes and natural 
killer cells.3-5 Biliary apoptosis and apotopes are regarded as the major effectors in the 
immune-mediated loss of bile ducts in PBC, and aberrant Fas (CD95) expression and dysregulation 
of the Bcl-2 family are observed in the damaged bile ducts, including CNSDC in PBC.6-8 In contrast, 
gender-based differences in the incidence of PBC have been speculated to be associated with 
hormonal factors, including oestrogen.9-12 Oestrogen, a sex steroid hormone, exhibits important 
biological functions, including proliferative effects, in target tissues. Oestrogen-stimulated growth in 
normal cells requires the oestrogen receptor (ER). Although bile ducts have not been considered a 
target of hormones, it was demonstrated that biliary epithelial cells (BECs), particularly rodent BECs, 
expressed ERs and oestrogen and have been speculated to play important roles in the pathogenesis of 
PBC.10-13 
ER forms homo- or hetero-dimers consisting of ERα and ERβ, which bind to an 
oestrogen-response element (ERE) and affect cell proliferation as well as the promotion of apoptosis 
and cell differentiation, respectively.14 Both ERα and ERβ are observed in bile ducts in the early 
stages of PBC, but the disappearance of ERα in bile ducts during the cirrhotic stage and oestrogen 
deficiency are speculated to accompany the evolution of PBC toward ductopenia.11 As the 
mechanism of cell proliferation via ERα (or ERs), an oestrogen response molecule, 
oestrogen-responsive finger protein (Efp), targets the 14-3-3σ protein for proteolysis as an ubiquitin 
ligase and stimulates cell growth.15 14-3-3σ is a negative regulator of cell cycle progression and is 
important for maintaining G2 arrest by sequencing phosphorylated Cdc2-cyclin B1 from the nucleus 
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into the cytosol.16 Moreover, Efp is predominantly expressed in the tissues and cells targeted by 
oestrogen, including the mammary gland and uterine epithelial cells.17 In contrast to ER, 
oestrogen-related receptors (ERRs) are constitutively active members of the nuclear hormone 
receptor superfamily without oestrogen or without binding to ERs. Although the functional 
mechanism of ERRs is complicated, ERRs bind to ERE as well as ERR-response element (ERRE), 
modulating oestrogen-induced and ER-dependent oestrogen effects via competition with ERs.18,19 
In this study, we investigated ER and ERR expression in human BECs along with the 
apoptosis-associated cell kinetics to clarify the effects of oestrogen and its association with the 
pathogenesis of cholangiopathy in PBC.  
 
MATERIALS AND METHODS 
 
Cell culture  
Two human intra-hepatic BEC lines were established from the explanted livers of females with PBC 
(BEC1 and BEC2).20 The cell lines were confirmed to be BECs by the expression of the biliary-type 
cytokeratins, CK7 and CK19, and BECs were used between passages 6 and 10 to maintain their 
characteristics. Moreover, cDNA samples in BEC1 at passage 3 was also used to confirm the stable 
expression of receptors and molecules examined in this study. As the positive control for ERs and 
ERRs, the breast cancer cell line MCF-7 was purchased from the Health Science Research 
Resources Bank (Osaka, Japan).21 
 
Cell viability on treatment with oestrogen and an ERRγ agonist 
Cultured cells were treated with oestrogen (17β-Oestradiol, E2, 10–200 pg/ml, Calbiochem, 
Darmstadt, Germany), GSK4716 (selective agonist at ERRβ and ERRγ, 10μM, Sigma-Aldrich, 
Japan, Tokyo, Japan), Bcl-2 inhibitor (167 μM, Calbiochem) and/or a pan-caspase inhibitor (40 μM, 
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Calbiochem). Cell proliferation was measured 24 h later using the DNA–IdU labelling and detection 
kit (Takara, Ohtsu, Japan) or the tetrazolium salt WST-1 (Roche, Penzberg, Germany).  
 
Treatment with E2 and the ERRγ agonist 
To evaluate the regulation of ERs and ERRs after stimulation with oestrogen and an ERR agonist, in 
serum- and phenol red-free conditions, cultured cells were treated with E2 (200 pg/ml) for 3 h or 24 h, 
and total RNA samples were used for the following molecular analysis. Reverse transcription 
(RT)-polymerase chain reaction (PCR) and real-time PCR were performed for the detection and 
measurement of mRNAs of ERs (α and β), Efp, 14-3-3σ, ERRs (α, β and γ) and the Bcl-2 family 
members. Total RNA was isolated using the RNeasy Total RNA System (Qiagen, Hilden, Germany) 
following the manufacturer’s instructions. For real-time PCR, quantitative analyses according to 
standard protocols using the SYBR Green PCR Master Mix and MX3000P (Stratagene, Tokyo, Japan) 
were performed. The specific primers for ERs, ERRs and GAPDH (positive control) were designed as 
presented in Table 1.  
 
Evaluation of transcription factors 
To evaluate the influence of ERRγ, the activation of ER-related transcription factors, ER, activator 
protein-1 (AP1)22 and stimulating protein-1 (SP1)23 were measured on the basis of the DNA-binding 
capacity of these transcription factors using a sensitive multi-well colorimetric assay according to the 
instruction manual (TransAM ER, AP1 and SP1 kits, respectively, Active Motif Japan, Tokyo, 
Japan).  
 
Patients and liver tissue preparation 
A total of 55 needle liver specimens were obtained from 25 patients with PBC (histological stage 1/2/3 
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= 3/14/8 and cholangitis activities CA0/1/2/3 = 2/6/4/13 by Nakanuma’s grading and staging 
system,24 mean age, 52 years, range, 42–80 years, all females) and from 30 females with no PBC 
(controls), including 3 patients with non-specific reactive changes, 13 with HCV-related chronic 
hepatitis, 1 with HBV-carrier, 8 with drug-induced liver injury and 5 with fatty liver (mean age, 49 
years, range, 33–64 years). Moreover, as control biliary diseases, surgically resected or explanted 
livers were also obtained from 3 patients with primary sclerosing cholangitis (PSC) and 4 with 
extrahepatic biliary obstruction. 
 
Immunohistochemistry 
The expression of ERβ, Efp, 14-3-3σ and ERRγ was immunohistochemically assessed. The 
deparaffinised sections were microwaved in 10-mM citrate buffer for 20 min in a microwave oven. 
Following the blocking of endogenous peroxidase, the deparaffinised sections were incubated 
overnight at 4°C with the primary antibody against ERβ (rabbit IgG, 2.5 μg/ml, Abcam, Tokyo, 
Japan), Efp (mouse IgG1, 1 μg/ml, BD, Tokyo, Japan), 14-3-3σ (mouse IgG1, 5 μg/ml, Abcam) or 
ERRγ (mouse IgG2a, 1 μg/ml, PPRX, Tokyo, Japan) and then at room temperature for 1 h with goat 
anti-mouse or anti-rabbit immunoglobulin conjugated to a peroxidase-labelled dextran polymer 
(Envision, Dako Japan, Tokyo, Japan). After a benzidine reaction, sections were counterstained with 
haematoxylin or methyl green. As negative controls, normal mouse IgG1, mouse IgG2a or rabbit IgG 
was used as the primary antibody.  
For semi-quantitative evaluation of the immunohistochemistry of ERRγ, 2 or 3 portal tracts 
containing interlobular bile ducts, including damaged bile ducts, were selected in each section for 
assessment, and the nuclear immunoreactivity in each bile duct was semi-quantitatively graded as 
follows: 0, absence of expression; 1, ≤1/3 positive cells; 2, 1/3–2/3 positive cells and 3, ≥2/3 positive 
cells. The final score indices for each patient were defined as the mean of individual cases.  









Effects of oestrogen on the proliferation of cultured BECs  
RT-PCR revealed that ERβ mRNA was amplified in human BECs cultured in standard medium, 
although the levels were lower than those in the positive control (MCF-7 cells; Fig. 1). In contrast, 
no clear amplification of ERα was evident. These expressions in BECs were stable until at least 
passage 9 (Supplemental figure 1). The stimulation with E2 did not induce significantly increased 
proliferation of human BECs, irrespective of the E2 levels (1–200 pg/ml; Fig. 2). In addition, the 
human BECs constantly expressed mRNAs of Efp and 14-3-3σ, as detected by RT-PCR (Fig. 1). 
These expressions in BECs were stable until at least passage 9 (Supplemental figure 1). Moreover, 
quantitative analysis using real-time PCR revealed that E2 (200 pg/ml) did not affect the Efp 
expression but up-regulated the 14-3-3σ expression (Fig. 3). Furthermore, immunohistochemistry 
revealed that BECs in the interlobular bile ducts constantly expressed ERβ, Efp and 14-3-3σ (Fig. 4). 
In addition, nuclear expression of ERβ was determined in BECs. In contrast, the expression of Efp 
and 14-3-3σ revealed a cytoplasmic pattern and was strong and weak, respectively, but did not 
change significantly with disease and age. 
 
ERR expression in BECs and its regulation by oestrogen 
RT-PCR demonstrated the mRNA expression of ERRα and ERRγ but not ERRβ in the human BECs 
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that were cultured in a standard medium (Fig. 1). These expressions in BECs were stable until at 
least passage 9 (Supplemental figure 1). Moreover, real-time PCR demonstrated that E2 (200 pg/ml) 
did not affect the expression of ERs (α and β) and ERRα but significantly decreased the ERRγ 
expression (Fig. 5).  
 
ERRγ expression in liver tissue 
Immunohistochemistry demonstrated the nuclear expression of ERRγ in several BECs of the 
interlobular bile ducts and bile ductules, hepatocytes and infiltrating inflammatory cells. BECs in the 
damaged bile ducts, including CNSDC in PBC, were particularly positive for ERRγ, but negative 
bile ducts were also scattered in young non-PBC patients (Figs. 6A and 6B). However, because the 
immunohistochemistry for ERRγ did not work in surgical and explanted liver specimens, the data of 
PSC and extrahepatic biliary obstruction were excluded in the following analysis. Furthermore, 
semi-quantitative analysis revealed the ERRγ expression in the interlobular bile ducts to be stronger 
in the middle- or old-aged females (>50 years) than in the younger females (≤50 years) and that in 
the middle- and old-aged females, PBC expression was up-regulated (Fig. 6C). Moreover, among the 
middle- or old-aged females with PBC, those with severe cholangitis activity (CA3) revealed high 
ERRγ expression in the bile ducts compared with those with no, mild, or moderate activities 
(CA0–CA2; Fig. 6C).  
 
Effects of the ERRγ agonist in cultured BECs 
Among ER-related transcription factors, as indicated by the results of DNA-binding capacity assays 
in Fig. 7, the ERRγ agonist GSK4716 activated the nuclear factor SP1 but not ER or AP1 in cultured 
human BECs. Because the promoters of many pro- and anti-apoptotic genes have been found to 
contain SP1-binding elements,25 we evaluated the regulation of the Bcl-2 family by GSK4716. 
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GSK4716 up-regulated the expression of the 2 pro-apoptotic proteins Bax and Bad but not that of the 
pro-apoptotic protein Bid or any other anti-apoptotic factors, including Mcl-1, Bcl-XL and Bcl-2 
(Fig. 8). To investigate the effects of the ERRγ agonist on the cell kinetics of cultured human BECs, 
we analysed cell viability using the WST-1 assay. As displayed in Fig. 9, treatment with GSK4716 or 
with the Bcl-2 inhibitor alone did not reduce the cell viability after 24 h, but together, the ERRγ 
agonist and Bcl-2 inhibitor significantly reduced the cell viability; moreover, this reduction was 




 One possible reason why PBC mainly affects females is that oestrogen worsens or attenuates 
the factors involved in the pathogenesis of this disease. Alvaro et al. used cultured rat BECs and 
reported that BECs (cholangiocytes) possessed both ERα and ERβ and that oestrogen treatment 
induced a significant increase in cell proliferation, suggesting that oestrogen deficiency was closely 
associated with the pathogenesis of PBC and that replacement treatment with oestrogen may 
attenuate the disease activity. However, our study revealed that human BECs had ERβ, but the 
functional expression of ERα was faint, and cell proliferation was not significantly increased by 
oestrogen treatment. The difference in the response to oestrogen between humans and rats is possibly 
because of the differences in ER expression between the 2 species,26 particularly ERα expression.  
14-3-3σ is a negative regulator of cell proliferation, and Efp proteolyses 14-3-3σ and promotes 
cell proliferation.15 The present study used cultured human BECs and human liver tissues and 
revealed that BECs constantly expressed both Efp and 14-3-3σ, suggesting that the proliferating 
activity of human BECs is negatively regulated by 14-3-3σ and that oestrogen could induce the 
proliferation of BECs. However, the presence of oestrogen did not result in any significant increase 
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in the proliferative activity. As a possible explanation for this discrepancy, we speculated the 
presence of other negative regulatory systems as well as a lack of functional expression of ERα. 
Therefore, we evaluated the regulation of Efp and 14-3-3σ expression and found that oestrogen 
up-regulated the expression of 14-3-3σ but not Efp. These findings suggest that oestrogen-induced 
Efp activation proteolyses 14-3-3σ and simultaneously induces the expression of 14-3-3σ, thereby 
affecting the negative regulation of oestrogen-induced cell proliferation. Although 
oestrogen-induced Efp activation generally targets 14-3-3σ for proteolysis, inducing an increase in 
the proliferative activity of the affected cells, it is unclear why E2 could not affect the proliferative 
activity of BECs by the up-regulation of 14-3-3σ expression. It is possible that the difference in 
these E2 functions is associated with the functions of the 2 oestrogen receptors ERα and ERβ. 
Moreover, although Efp expression was constantly found in the interlobular bile ducts of all patients, 
including pre-menopausal females, the distinct down-regulation of 14-3-3σ was not determined in 
any age or disease, which supports the presence of the up-regulation system of 14-3-3σ in BECs.  
 
ERRs are constitutively active members of the nuclear hormone receptor superfamily without 
oestrogen or without binding to ERs and inhibit oestrogen-induced and the ER-dependent effects of 
oestrogen by competing with ERs.18,19 The present study used cultured human BECs and revealed 
that BECs expressed ERRα and ERRγ, thereby suggesting that these ERRs could regulate biliary 
oestrogen signalling via ERs. Moreover, the presence of oestrogen down-regulated the ERRγ 
expression; in addition, the ERRγ levels in the interlobular bile ducts was lower in the younger 
females than in the middle- and old-aged females, suggesting that the bile ducts of younger females 
are easily affected by oestrogen considering a relative insusceptibility to the inhibitory effects of 
ERRγ. In contrast, the bile ducts among the middle- and old-aged females, particularly those with 
marked activity of chronic cholangitis (CA3)24 in PBC, revealed significantly increased the ERRγ 
expression compared with those in the non-PBC females. Thus, under the conditions of low serum 
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oestrogen levels in the middle- and old-aged females, ERRγ function is speculated not to compete 
with oestrogen. 
Next, to clarify the significance of highly expressed ERRγ in the damaged bile ducts of PBC, 
we first examined the ER-related transcription factors activated by ERRγ in human BECs. The ERRγ 
agonist GSK4716 activated SP1 but not ER or AP1 in BECs. Although ER, AP1 and SP1 are all 
known ER-related transcription factors,22,23 ERRγ was associated with SP1 in human BECs, 
suggesting an interaction between ER and ERRγ in the intra-cellular signalling via SP1 and its 
related transcription. Next, because the SP1-binding site is located within the promoter regions of 
several apoptosis-related molecules,25 we evaluated the expression of the Bcl-2 family members 
associated with apoptosis. GSK4716 induced the up-regulation of the 2 pro-apoptotic molecules Bad 
and Bax but not of any anti-apoptotic molecules in human BECs. As a mechanism of the bile duct 
loss in PBC, several previous studies have demonstrated that enhanced biliary apoptosis was 
associated with the Bcl-2 family and Fas (CD95).6,7 Our previous study has revealed that the 
expression of a pro-apoptotic factor, Bax, was predominant in the damaged bile ducts in PBC 
compared with that of the anti-apoptotic Mcl-1 and Bcl-XL.27 Moreover, combined treatment with 
the ERRγ agonist and Bcl-2 inhibitor significantly reduced the viability of the cultured human BECs, 
and this reduction was completely rectified by pre-treatment with a caspase inhibitor, suggesting that 
the reduced cell viability is caused by enhanced biliary apoptosis. Therefore, it is speculated that the 
increased susceptibility to biliary apoptosis caused by ERRγ- and SP1-associated transcriptional 
signalling is closely associated with the pathogenesis of bile duct loss in PBC.  
In conclusion, the functional expression of ERRs in human BECs is suggested to play a role in 
regulating the effects of oestrogen by competing with ERs. In the younger females, the ERRγ 
expression in the bile ducts is inhibited by increased serum levels of oestrogen, and the 
ER-dependent effects of oestrogen could be predominant. In contrast, increased the ERRγ expression 
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followed by increased susceptibility to biliary apoptosis in the bile ducts, particularly the damaged 
bile ducts, of middle- or old-aged females, including post-menopausal females, is an important 
finding to understand the pathogenesis of cholangiopathy in PBC.  
 
 
Take home messages 
- Human biliary epithelial cells express ERβ, and oestrogen treatment does not induce significant 
cell proliferation.  
- Although oestrogen down-regulates the ERRγ expression, the increased ERRγ expression under 
oestrogen-deficient conditions increases the susceptibility to Bcl-2 family-mediated apoptosis in 
human BECs of females, particularly those with PBC.  
- Understanding this oestrogen-mediated cell kinetics is important for elucidating the pathogenesis of 
cholangiopathy in PBC. 
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Table 1 Primers used for RT-PCR and quantitative PCR 
 
-------------------------------------------------------------------------------------------------------------- 
 Transcript                Primers                            Product size  
-------------------------------------------------------------------------------------------------------------- 
ERα      Forward 5’-TTTGCATCCAATTGTGCCTGA-3’      103 bp 
Reverse 5’-TGTTGTTTCTAGGGTGCACAGCTC-3’  
ERβ    Forward 5’-GATGCTCCTGTCCCACGTCA-3’        111 bp 
Reverse 5’-CACTGCTCCATCGTTGCTTCA-3’ 
Efp    Forward 5’-GCATCTGCCACATCTGCCTG-3’         296 bp 
Reverse 5’-GCTGTTGACCCTCTTCTCCTCTTC-3’   
14-3-3σ     Forward 5’-AGAGACACAGAGTCCGGCATTGG-3’    290 bp 
Reverse 5’-TCCACCTTCTCCCGGTACTCACGC-3’ 
ERRα   Forward 5’-CTTGGCCCTTGCCAATTC-3’        102 bp 
Reverse 5’-CCGGCTTCATACTCCAGCAG-3’   
ERRβ   Forward 5’-CAGGCAGATCTCACCCAGCA -3’     148 bp 
Reverse 5’-TGAGGTCACTCGCAGCAACAC-3’   
ERRγ    Forward 5’-TGAAACATCAACCCAGTGCT-3’     196 bp 
Reverse 5’-AAGGGATGTGCCAATTTCTG-3’   
Bad    Forward 5’-CCGAGTGAGCAGGAAGACTC-3’     205 bp 
Reverse 5’-GGTAGGAGCTGTGGCGACT-3’ 
Bid    Forward 5’-GCAGGCCTACCCTAGAGACA-3’       181 bp 
Reverse 5’-GTCCATCCCATTTCTGGCTA-3’ 
Bax    Forward 5’-TTTGCTTCAGGGTTTCATCC-3’   162 bp 
Reverse 5’-ATCCTCTGCAGCTCCATGTT-3’ 
Mcl-1   Forward 5’-TGCTGGAGTAGGAGCTGGTT -3’     176 bp 
Reverse 5’-CCTCTTGCCACTTGCTTTTC-3’ 
Bcl-XL    Forward 5’-GTAAACTGGGGTCGCATTGT-3’       146 bp 
Reverse 5’-TGGATCCAAGGCTCTAGGTG-3’ 
Bcl-2    Forward 5’-TGTGGATGACTGAGTACC-3’    117 bp 
Reverse 5’-AGGAGAAATCAAACAGAGG-3’        









Fig. 1 The expression of oestrogen receptor (ER) α, ERβ, oestrogen-responsive finger protein (Efp), 
14-3-3σ, oestrogen-related receptor (ERR) α, ERRβ and ERRγ. RT-PCR analysis using 
cultured biliary epithelial cells (BECs) and MCF-7 (used as positive controls) was 
performed for 40 cycles except for GAPDH (35 cycles) to survey the presence or absence of 
amplifications and confirm the absence of non-specific amplifications. BECs expressed 
mRNAs of ERβ, Efp, 14-3-3σ, ERRα, ERRγ and the positive control (GAPDH). However, 
ERα expression is faint, and no amplification of ERRβ is evident. Each PCR product 
provides bands of the appropriate molecular weight. N/C, distilled water instead of reverse 
transcriptase (negative control) for reverse transcription. 
 
Fig. 2 Assessment of cell viability using the DNA–IdU labelling. Human biliary epithelial cells 
cultured in serum- and phenol red-free media were treated with oestrogen (17β-Oestradiol, 
E2, 10–200 pg/ml), and the degree of cell proliferation was measured 24 h later. Results 
were obtained from 2 independent experiments and were shown relative to the levels 
without oestrogen treatment. No significant differences were observed, irrespective of the 
presence of oestrogen. The bars indicate the mean ± S.E.M values. 
 
Fig. 3 The effects of oestrogen on the expression of oestrogen-responsive finger protein (Efp) and 
14-3-3σ. Human biliary epithelial cells cultured in serum- and phenol red-free media were 
treated with oestrogen (17β-Oestradiol, E2, 10–200 pg/ml) for 3 h. Quantitative analysis 
using real-time PCR revealed that oestrogen significantly up-regulated the 14-3-3σ mRNA 
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expression by 2.7 ± 0.6-fold (mean ± S.E.M) but not the Efp expression. Results obtained 
from 2 independent experiments are presented relative to the levels without oestrogen 
treatment (vehicle control). The bars indicate the mean ± S.E.M values. * <0.05. 
 
Fig. 4 Immunohistochemical staining of oestrogen receptor β (ERβ, A), oestrogen-responsive 
finger protein (Efp, B) and 14-3-3σ (C). A: Primary biliary cirrhosis (PBC). Biliary 
epithelial cells in the normal interlobular bile ducts (arrow) and bile ductules express ERβ 
in the nucleus. B: HCV-related chronic hepatitis. Strong cytoplasmic expression of Efp is 
evident in the bile ducts (arrow). C: Primary sclerosing cholangitis. Marked expression of 
Efp is found in the bile ducts (arrow). D: PBC. Damaged bile ducts expressed 14-3-3σ in 
the cytoplasm (arrow). The staining patterns are constant, and significant differences are 
evident among the diseases and age groups. 
Fig. 5 The effects of oestrogen on the oestrogen receptors (ERs) and oestrogen-related receptors 
(ERRs). Human biliary epithelial cells cultured in serum- and phenol red-free media were 
treated with oestrogen (17β-Oestradiol, E2, 200 pg/ml) for 3 h. Quantitative analysis using 
real-time PCR revealed a relative decrease in the ERRγ mRNA expression by 0.39 ± 
0.17-fold (mean ± S.E.M), compared with no treatment (non, vehicle control). In contrast, 
ERα, ERβ and ERRα were not affected by oestrogen. The results were obtained from 2 
independent experiments and were shown relative to the levels without oestrogen treatment. 
The bars indicate the mean ± S.E.M values. * <0.05. 
Fig. 6 Immunohistochemistry of oestrogen-related receptor γ (ERRγ). A: Primary biliary cirrhosis 
(PBC). The immunoreaction to ERRγ was restricted to the nucleus, and most biliary 
epithelial cells were positive in the damaged bile duct (CNSDC, arrow). B: HCV-related 
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chronic hepatitis. The positive and negative cells are inter-mingled in the mildly damaged 
bile ducts (hepatic bile duct injury, arrow). C: Semi-quantitative analysis demonstrated that 
the ERRγ expression was higher in the inter-lobular bile ducts of the middle- or old-aged 
females (>50 years) than in those of the younger females (≤50 years). In the middle- or 
old-aged females, the ERRγ expression was predominantly evident in PBC when compared 
with the non-PBC diseased livers (controls). Moreover, among the middle- or old-aged 
females with PBC, the patients with severe cholangitis activity (CA3 by Nakanuma’s 
grading system for PBC) revealed high ERRγ expression in the bile ducts when compared 
with those with no, mild or moderate activities (CA0–CA2). The bars indicate the mean ± 
S.E.M values. * <0.05. 
Fig. 7 The 3 transcription factors oestrogen receptor (ER), activator protein-1 (AP1) and 
stimulating protein-1 (SP1) and the DNA binding assay of the ERRγ agonist GSK4716 (10 
μM)-induced activation in the cultured human biliary epithelial cells. The results are 
presented as optical density (OD). The activation of ER and AP1 by GSK4716 was similar 
to that without treatment (vehicle control). In contrast, although the baseline levels of SP1 
(vehicle) were slightly increased, GSK4716 increased the SP1 activation by 2.3-fold. Data 
using cultured human cells (BEC1) are presented. P/C, positive controls were used in the 
enclosed samples of each kit. Each DNA-transcription factor binding activity was 
effectively competed for by the wild-type consensus oligonucleotide but not by the mutated 
oligonucleotide (data not shown).  
Fig. 8 The effects of ERRγ on the mRNA expression of the Bcl-2 family. The human biliary 
epithelial cells were treated with the ERRγ agonist GSK4716 (10 μM) for 3 h. Quantitative 
analysis using real-time PCR revealed that among the pro-apoptotic molecules, the 
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expression of Bad and Bax (A) significantly increased by 1.75 ± 0.21- and 1.50 ± 0.11-fold 
(mean ± S.E.M), respectively, compared with no treatment (vehicle control). However, the 
pro-apoptotic protein Bid (A) and the anti-apoptotic factors Mcl-1, Bcl-XL and Bcl-2 (B) 
were not affected by the ERRγ agonist. The results were obtained from 2 independent 
experiments and were shown relative to the levels without GSK4716. The bars indicate the 
mean ± S.E.M values. * <0.05. 
Fig. 9 The effects of the ERRγ agonist GSK4716 on Bcl-2 inhibitor-induced apoptosis. Combined 
treatment with GSK4716 (10 μM) and the Bcl-2 inhibitor (167 μM) significantly reduced 
the viability of the cultured human biliary epithelial cells for 24 h, and this reduction was 
rectified by pre-treatment with pan-caspase inhibitor (40 μM), although GSK4716 or the 
Bcl-2 inhibitor alone did not reduce cell viability. The results were obtained from 2 
independent experiments using the WST-1 assay. The bars indicate the mean ± S.E.M. * 
<0.05. 
 
Supplemental figure 1.  The expression of oestrogen receptor (ER) α, ERβ, oestrogen-responsive 
finger protein (Efp), 14-3-3σ, oestrogen-related receptor (ERR) α, ERRβ and ERRγ mRNAs 
in cultured biliary epithelial cell 1 (BEC1) at the passage indicated. Quantitative analysis 
using real-time PCR revealed that the expressions of all receptors/molecules were 
maintained, though the expression of ERRγ was halved between passages 3 and 6. Results 
are presented as relative ratio (%) to those in MCF-7 (used as positive controls). 
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